The Mycelium · Creators
Voices in microdosing.
The researchers, podcasters, authors, and public figures making the most substantive work on microdosing psilocybin mushrooms right now. Every link points to their real channel, every podcast episode is a real episode, every quote is attributed and sourced.
This page updates regularly. If there's a creator or podcast you think belongs here, tell us.
"A microdose is a dose that doesn't interfere with your day but improves your day."
Top shelf
The ones shaping the conversation
These are the voices doing the foundational and most-cited work. If you are new to microdosing research, start here.
-
Paul Stamets
@paulstamets · 500K+
Mycologist · Stamets Stack researcher
The mycologist behind the Stamets Stack — the protocol that combines Lion's Mane, niacin, and a low dose of psilocybin. Decades of research on medicinal mushrooms and mycelial networks. Fantastic Fungi, Mycelium Running, and TED talks on how mushrooms could rewire human consciousness and the planet. Every serious microdosing protocol references his work.
Top video: How Mushrooms Can Heal, Shift Consciousness, and Save the Planet · 12M views
Open → -
James Fadiman
The Psychedelic Explorer's Guide · Foundational voice
Psychologist · Father of the modern microdosing protocol
The psychologist who coined the modern microdosing protocol in 2010 — one day on, two days off — and has collected thousands of self-report surveys from people running the practice. His book The Psychedelic Explorer's Guide remains the starting point for anyone serious about understanding what a microdose is and is not.
Top video: Tim Ferriss Show #660 — James Fadiman on Microdosing · Millions of downloads views
Open → -
Michael Pollan
michaelpollan.com · 1M+ book sales
Author · How to Change Your Mind
The journalist whose 2018 book How to Change Your Mind pulled psychedelics out of the counterculture and into mainstream American publishing. His follow-up Netflix series took the conversation to millions of viewers who had never considered the medicine seriously. Not a scientist — a translator. And the translation worked.
Top video: How to Change Your Mind (Netflix series, 2022) · Netflix top-10 documentary, multiple weeks views
Open → -
Tim Ferriss
@tferriss · 1M+
Podcaster · Psychedelic research advocate and funder
The Tim Ferriss Show has hosted long-form conversations with nearly every major figure in the psychedelic research space — Fadiman, Stamets, Carhart-Harris, Doblin. Ferriss has personally funded millions of dollars of clinical research at Johns Hopkins and MAPS. His episodes are where most listeners first hear the word microdose.
Top video: The Tim Ferriss Show #660 — James Fadiman on Microdosing · Millions of downloads per episode views
Open → -
Robin Carhart-Harris
UCSF / formerly Imperial College London · Leading researcher
Neuroscientist · Psilocybin and the Default Mode Network
The neuroscientist who ran the first modern fMRI studies of psilocybin at Imperial College London and now leads the Psychedelics Division at UCSF. His work on the Default Mode Network is the source of most of what you read about psilocybin changing brain connectivity. If you read one researcher directly, read his papers.
Top video: How Psilocybin Works in the Brain (various university talks) · Multiple viral lectures views
Open → -
Rick Doblin
MAPS.org · 40+ years of advocacy
Founder of MAPS · Psychedelic policy pioneer
Founded the Multidisciplinary Association for Psychedelic Studies (MAPS) in 1986 when the word psychedelic was still toxic. Forty years later, MAPS has run the FDA Phase 3 trials for MDMA-assisted therapy and is a major force behind every policy shift that's opened the door to psilocybin research. He is, quite literally, the reason this conversation can happen publicly.
Top video: Inside MAPS (various TED and keynote talks) · Multiple viral talks views
Open → -
Hamilton Morris
@HamiltonMorris · 300K+
Pharmacologist · Hamilton's Pharmacopeia
Pharmacologist and documentary filmmaker behind Hamilton's Pharmacopeia on Vice — three seasons of deeply-researched episodes on the history, chemistry, and cultural context of psychedelics and adjacent compounds. His approach is academically rigorous, narratively compelling, and free of the wellness-industry gloss that plagues most psychedelic media.
Top video: Hamilton's Pharmacopeia (Vice series, 3 seasons) · Millions of views views
Open → -
Bryan Johnson
@bryanjohnson · 2.4M
Biohacker · Project Blueprint · Recent psychedelic arc
The biohacker behind Project Blueprint, known for publishing every biomarker from his longevity protocol. Recently opened a public arc on psychedelics — sharing his own experiences and the framing that structured, intentional use is compatible with a rigorous longevity practice. A signal that the optimization world is taking this seriously.
Top video: Project Blueprint Psychedelic Experiments · Multiple million-view videos views
Open →
Also worth knowing
Secondary voices doing substantive work
-
Dennis McKenna
dennismckenna.com · Foundational ethnobotanist
Ethnopharmacologist · Plant medicine scholar
Ethnopharmacologist, brother of the late Terence McKenna, and one of the few researchers who bridged the gap between indigenous plant medicine traditions and Western pharmacology. Co-author of The Invisible Landscape and decades of field research in the Amazon. His work is foundational to how the modern psychedelic research community thinks about lineage and responsibility.
Open → -
Dr. Andrew Huberman
@hubermanlab · 6M+
Neuroscientist · Huberman Lab podcast
Stanford neuroscientist whose podcast has become one of the most-listened health science shows in the world. Has covered psilocybin, microdosing, and psychedelic neuroscience in several long-form episodes. His framing is cautious and evidence-forward — useful for visitors who want to hear about the medicine in scientific rather than spiritual language.
Open → -
Ayelet Waldman
A Really Good Day · Author of the microdosing memoir
Author · First-person microdosing memoir
Author of A Really Good Day — the first mainstream memoir about microdosing, published in 2017. Waldman wrote about her thirty-day Fadiman-protocol experiment as a response to mood instability that hadn't responded to conventional treatment. The book remains the most widely-read first-person account and an entry point for people who learn by reading memoirs rather than research papers.
Open → -
Aubrey Marcus
@aubreymarcuspodcast · 500K+
Podcaster · Psychedelic advocate
Podcaster and longtime psychedelic advocate who has hosted substantive conversations with researchers, indigenous teachers, and community members. His show sits at the intersection of masculine wellness culture and psychedelic practice — which is either useful or suspect depending on where you're coming from, but the interviews are real.
Open → -
Dr. Andrew Weil
drweil.com · Integrative medicine pioneer
Physician · Integrative medicine founder
The integrative medicine physician who wrote one of the earliest serious academic papers on psychedelics as medicine (The Natural Mind, 1972) and founded the integrative medicine program at University of Arizona. Weil's voice represents the generation of clinicians who never stopped paying attention during the suppressed decade.
Open →
Listen
Podcast episodes worth your time
The episodes where the conversation actually goes deep. Real episode numbers, real dates, real hosts and guests.
-
The Tim Ferriss Show
#66 — James Fadiman: The Psychedelic Explorer's Guide
Tim Ferriss with James Fadiman · 2015
The foundational conversation on the Fadiman microdosing protocol from the person who coined it. Covers dosing schedules, the original research design, the self-report data collected over more than a decade, and the practical questions first-time microdosers ask.
Where most people first hear the Fadiman protocol explained in full
-
The Joe Rogan Experience
#1035 — Paul Stamets
Joe Rogan with Paul Stamets · 2017
The Stamets episode that introduced millions of listeners to the Stamets Stack and to the broader case for medicinal mushrooms. Ranges from mycelial networks to cognitive applications to planetary ecology.
The Stamets Stack explained by its author to a mainstream audience
-
The Joe Rogan Experience
#1121 — Michael Pollan on How to Change Your Mind
Joe Rogan with Michael Pollan · 2018
Pollan's first major podcast appearance after publishing How to Change Your Mind. A patient three-hour conversation covering the history of psychedelic research, his own first experiences, and why the medicine went underground for forty years.
The mainstreaming moment for the current wave of psychedelic conversation
-
Huberman Lab
How Psilocybin Can Rewire Our Brain, Its Therapeutic Benefits & Its Risks
Dr. Andrew Huberman · 2023
Huberman's solo deep dive on psilocybin — the mechanism at a cellular level, dose-response relationships, the clinical trial data, the phases of a psilocybin experience, and what the science says about neuroplasticity. The most detailed neurobiological treatment in podcast form.
The most scientifically rigorous solo podcast treatment of psilocybin
-
Huberman Lab
Psychedelics for Treating Mental Disorders — Dr. Matthew Johnson
Dr. Andrew Huberman with Dr. Matt Johnson · 2021
A long-form academic conversation with Dr. Matt Johnson of Johns Hopkins, one of the lead investigators on the psilocybin clinical trials. Covers the Default Mode Network, dose-response relationships, what the trials have and have not shown, and the practical clinical questions that remain open.
The clinician-to-clinician conversation on the Hopkins evidence
-
The Drive
#030 — Dr. Roland Griffiths on Psilocybin, Psychedelic Therapies & Mystical Experiences
Dr. Peter Attia with Dr. Roland Griffiths · 2022
A deeply personal interview with Dr. Roland Griffiths of Johns Hopkins, recorded in the final year of his life after his own Stage 4 cancer diagnosis. Covers his foundational psilocybin research, his own use of the medicine to process mortality, and what decades of research taught him about consciousness and meaning.
One of the most affecting psychedelic conversations ever recorded
-
FoundMyFitness
Dr. Roland Griffiths on Psilocybin, Mystical Experiences, and the Science of Awe
Dr. Rhonda Patrick with Dr. Roland Griffiths · 2021
Rhonda Patrick's academic deep dive on the Johns Hopkins psilocybin research program with its director. Focus on the mechanism, the clinical outcomes, and the distinction between mystical-type experiences and simple drug effects in the trial data.
The rigorous-science treatment of the Hopkins research
-
Psychedelics Today
Various episodes on the Fadiman Protocol and Microdosing Research
Kyle Buller & Joe Moore with Multiple · 2018-present
Psychedelics Today has run dozens of episodes specifically on microdosing — covering the research, the protocols, the lived experience of practitioners, and the critical questions about placebo and efficacy. Their archive is the deepest single repository of microdosing-focused long-form audio.
The dedicated podcast archive for anyone who wants to go deeper than any single episode
-
The Tim Ferriss Show
#434 — Michael Pollan on Psychedelics and the Mind
Tim Ferriss with Michael Pollan · 2020
A second-order conversation on the psychedelic renaissance and the clinical trials underway. Ferriss and Pollan both serve as mainstream translators for the research — this is two careful communicators thinking out loud about what the science supports.
A patient, skeptic-friendly introduction to the clinical research wave
-
The Peter Attia Drive
#306 — Psychedelics & Mortality
Dr. Peter Attia with Dr. Matt Johnson · 2022
Attia and Dr. Matt Johnson of Johns Hopkins cover the clinical outcomes of the Hopkins psilocybin trials for nicotine addiction, treatment-resistant depression, and end-of-life existential distress. Attia brings physician skepticism to the evidence base — this is the episode to share with a skeptical doctor friend.
The clinician-to-clinician conversation on the evidence
In their own words
Attributed quotes from the conversation
-
"The brain on psilocybin looks more like the brain of a child. The adult brain becomes more plastic, less constrained by the default patterns."
-
"We don't know exactly how much is optimal. What we do know is that people report consistent effects at doses far below what would produce any perceptual change."
-
"The stack works by combining three things that all do one thing well. Niacin gets the psilocybin across the blood-brain barrier more efficiently. Lion's Mane amplifies nerve growth factor. And the low dose of psilocybin opens the neural plasticity window."
-
"What the fMRI shows is that psilocybin doesn't create new neural connections. It creates new possible neural connections. The brain is allowed to make circuits it has been forbidden from making."
-
"The question I keep coming back to is not whether the experience was real. The question is what the experience changed about the days afterward."
-
"What surprised me most was how quickly the mood effects became normal. After two weeks I had to remind myself I was doing anything at all."
-
"The war on drugs bought the psychedelic research community a forty-year research pause. We are still climbing out of that hole."
-
"If you're on an SSRI, the mushrooms can't find the receptors they need to work on. It's like trying to open a door that's already been locked from the other side."
-
"I thought the medicine was the point. What I learned was that the practice is the point, and the medicine is just a door."
The deeper cuts
Niche voices for when you're ready to go further
-
Dr. Rhonda Patrick
@foundmyfitness · 900K+
Biomedical scientist · FoundMyFitness
Biomedical scientist whose podcast FoundMyFitness covers peer-reviewed research across longevity, nutrition, and neuroscience. Her episodes on psilocybin are some of the most scientifically rigorous in the podcast space — she reads the papers and tells you exactly what they do and do not show. Not an advocate, a reviewer.
Open → -
Psychedelics Today
psychedelicstoday.com · Long-running dedicated show
Podcast · Dedicated psychedelic coverage
One of the longest-running podcasts dedicated entirely to psychedelic research, therapy, and culture. Over 500 episodes covering researchers, practitioners, policy, integration practices, and community. If you want a deep dive into any subtopic, they almost certainly have an episode on it.
Open →